Cambodia vs Mauritania: Access to anti-retroviral drugs, male
Cambodia
96.0%
in 2024
Mauritania
97.0%
in 2024
Cambodia rank
3rd
Mauritania rank
2nd
Access to anti-retroviral drugs, male over time
- Cambodia
- Mauritania
How they compare
Mauritania currently reports 97.0% against 96.0% in Cambodia, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Mauritania ahead.
Cambodia ranks 3rd and Mauritania ranks 2nd of 141 countries.
Cambodia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cambodia | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.4% | 3.7% | 12.7% | Cambodia |
| 2010s | 62.4% | 33.4% | 29.0% | Cambodia |
| 2020s | 86.6% | 79.4% | 7.2% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Cambodia or Mauritania?
- Mauritania, at 97.0% against 96.0% in Cambodia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Cambodia and Mauritania?
- 1.0%, with Mauritania ahead.
- How many years of comparable data are there for Cambodia and Mauritania?
- 25 years are reported by both, from 2000 to 2024.
- How do Cambodia and Mauritania rank globally for access to anti-retroviral drugs, male?
- Cambodia ranks 3rd and Mauritania ranks 2nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.